Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy
Conditions: Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Malignant Neoplasm; Recurrent Plasma Cell Myeloma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Aggressive Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma; Refractory Malignant Neoplasm; Refractory Plasma Cell Myeloma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Interventions: Radiation: Fluorine F 18-fluoroazomycin Arabinoside; Procedure: Positron Emission Tomography Sponsor: University of California, San Francisco Suspended
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials